name:-0.017196178436279
name:-0.013606071472168
name:-0.0089700222015381
Astex Pharmaceuticals, Inc. Patent Filings

Astex Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Astex Pharmaceuticals, Inc..The latest application filed is for "compounds and methods for manufacture of hypomethylating agents".

Company Profile
7.19.14
  • Astex Pharmaceuticals, Inc. - Pleasanton CA US
  • ASTEX PHARMACEUTICALS, INC. - Dublin CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds And Methods For Manufacture Of Hypomethylating Agents
App 20220144881 - MIYAKE; Masahiro ;   et al.
2022-05-12
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
App 20220000900 - Phiasivongsa; Pasit ;   et al.
2022-01-06
Drug formulations
Grant 11,058,705 - Joshi-Hangal , et al. July 13, 2
2021-07-13
Oligonucleotide analogues incorporating 5-aza-cytosine therein
Grant 10,933,079 - Phiasivongsa , et al. March 2, 2
2021-03-02
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
App 20200215092 - Phiasivongsa; Pasit ;   et al.
2020-07-09
Drug Formulations
App 20200155588 - JOSHI-HANGAL; Rajashree ;   et al.
2020-05-21
Drug Combinations
App 20200009247 - AZAB; Mohammad ;   et al.
2020-01-09
Drug formulations
Grant 10,517,886 - Joshi-Hangal , et al. Dec
2019-12-31
Oligonucleotide analogues incorporating 5-aza-cytosine therein
Grant 10,456,415 - Phiasivongsa , et al. Oc
2019-10-29
Drug Formulations
App 20180369267 - JOSHI-HANGAL; Rajashree ;   et al.
2018-12-27
Drug formulations
Grant 9,913,856 - Joshi-Hangal , et al. March 13, 2
2018-03-13
Pharmaceutical Compositions For Increasing The Bioavailability Of Poorly Soluble Drugs
App 20170360791 - Joshi-Hangal; Rajashree ;   et al.
2017-12-21
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
App 20170035794 - Phiasivongsa; Pasit ;   et al.
2017-02-09
Lyophilized Pharmaceutical Compositions
App 20170000738 - JOSHI-HANGAL; Rajashree ;   et al.
2017-01-05
Drug formulations
App 20160346310 - JOSHI-HANGAL; Rajashree ;   et al.
2016-12-01
Oligonucleotide analogues incorporating 5-aza-cytosine therein
Grant 9,480,698 - Phiasivongsa , et al. November 1, 2
2016-11-01
Drug formulations
Grant 9,381,207 - Joshi-Hangal , et al. July 5, 2
2016-07-05
Oligonucleotide analogues incorporating 5-aza-cytosine therein
Grant 9,358,248 - Phiasivongsa , et al. June 7, 2
2016-06-07
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
App 20160130296 - Phiasivongsa; Pasit ;   et al.
2016-05-12
Drug Combinations
App 20160015805 - AZAB; Mohammad ;   et al.
2016-01-21
Protein kinase inhibitors
Grant 8,999,988 - Hurley , et al. April 7, 2
2015-04-07
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
App 20130236536 - Phiasivongsa; Pasit ;   et al.
2013-09-12
Oligonucleotide analogues incorporating 5-aza-cytosine therein
Grant 8,461,123 - Phiasivongsa , et al. June 11, 2
2013-06-11
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
Grant 8,445,502 - Bearss , et al. May 21, 2
2013-05-21
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed